Biogen (BIIB) Trades Lower After Roche (RHHBY) Alzheimer's Trial Halted; RBC Comments
Tweet Send to a Friend
Biogen (NASDAQ: BIIB) edged lower premarket after Roche (OTC: RHHBY)
said it would stop its phase III study of Alzheimer's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
said it would stop its phase III study of Alzheimer's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
